Navidea Biopharmaceuticals Inc (NAVB)

Oncology Corporate Profile

HQ Location

5600 Blazer Parkway, Suite 200
Dublin, OH 43017

Company Description

Navidea Biopharmaceuticals is a global leader in precision diagnostics which pinpoint molecular sites and pathways to identify the presence and status of disease. Through our innovative and flexible platforms and products, we are committed to improving diagnostic accuracy, empowering clinical decision-making and enhancing patient care. The Company focuses on the development and commercialization of innovative precision diagnostic agents that can and will make a difference for individuals ' and families, physicians and care givers ' touched by devastating conditions like cancer, dementia and movement disorders.

Website: http://navidea.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NAV-1800monoclonal antibodyColorectal cancerI

View additional information on product candidates here »

Source: http://navidea.com/

Recent News Headlines

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/26/2017 06:18 am

5/26/2017 06:18 am

5/26/2017 06:18 am

5/26/2017 06:18 am

5/16/2017 12:18 pm

5/16/2017 12:18 pm

5/16/2017 12:18 pm

5/16/2017 12:18 pm

5/10/2017 06:18 pm

5/10/2017 06:18 pm

5/10/2017 06:18 pm

5/10/2017 06:18 pm

5/9/2017 06:18 pm

4/25/2017 12:18 pm

Navidea reports 4Q loss

3/29/2017 09:00 pm

Navidea reports 4Q loss

3/29/2017 09:00 pm

Navidea Provides Corporate Update and Reports Full Year 2016 Results

3/29/2017 08:00 pm

[Business Wire] - Navidea Biopharmaceuticals, Inc. today reported business and financial highlights for the fourth quarter and year ended December 31, 2016.